乳是心脏保护的盟友还是血栓的威胁?
Eva Lindner1, Musa'ab Moh'd Alhmouz1, Raghad Abuhalimeh2
1Heart, Vascular & Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
JACC. Case reports
|September 19, 2025
概括
乳,以雌激素模仿效应而闻名,可能与深静脉血栓症 (DVT) 有关. 这一案例凸显了需要考虑补充剂作为潜在的DVT原因.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
- 血液学 血液学 血液学
背景情况:
- 乳 (Silybum marianum) 具有类似雌激素的特性.
- 雌激素活性引发了对静脉血栓栓塞的潜在贡献的担忧.
- 了解血栓形成的潜在阳性原因对于患者的安全至关重要.
研究的目的:
- 报告一个可能与牛 consumption相关的深静脉血栓症 (DVT) 病例.
- 综述当前关于乳的心血管作用和血栓形成潜力的文献.
- 强调考虑食补充剂在无法解释的血栓形成的差异诊断中的重要性.
主要方法:
- 一个41岁的男性患有特异性深静脉血栓症的病例介绍.
- 进行全面的诊断工作,以排除已知的高凝血状态和诱发因素.
- 多学科团队讨论和广泛的文献评论.
主要成果:
- 患者呈现深静脉血栓症,没有可识别的诱发因素或高凝血条件.
- 所有标准的实验室和临床研究对血栓形成风险因素都是负面的.
- 鉴定出牛使用与发生深静脉血栓形成之间的潜在关联.
结论:
- 这一案例表明,乳补充剂与静脉血栓形成之间可能存在联系.
- 乳的雌激素活性需要进一步研究其在心血管健康和血栓形成中的作用.
- 需要进一步的临床研究来阐明乳的复杂心血管作用,并指导临床实践.
相关概念视频
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Cardiomyopathy V: Interprofessional Care
339
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
339
Myocarditis IV: Nursing Management
209
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
209
Myocarditis I: Introduction
374
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
374
Myocarditis III: Medical Management
175
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
175
Cardiomyopathy III: Hypertrophic Cardiomyopathy
414
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414


